D
Douglas R. Stewart
Researcher at National Institutes of Health
Publications - 107
Citations - 4432
Douglas R. Stewart is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pleuropulmonary blastoma & Germline mutation. The author has an hindex of 33, co-authored 103 publications receiving 3013 citations. Previous affiliations of Douglas R. Stewart include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
David T. Miller,Kristy Lee,Wendy K. Chung,Adam S. Gordon,Gail E. Herman,Teri E. Klein,Douglas R. Stewart,Laura M. Amendola,Kathy Adelman,Sherri J. Bale,Michael H. Gollob,Steven M. Harrison,Ray E. Hershberger,Kent D. McKelvey,C. Sue Richards,Christopher N. Vlangos,Michael S. Watson,Christa Lese Martin +17 more
TL;DR: Clinicians are encouraged to document the reasons for the use of a particular procedure or test, whether or not it is in conformance with this statement, and to consider whether intellectual property interests may restrict the performance of certain tests and other procedures.
Journal ArticleDOI
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Markku Miettinen,Cristina R. Antonescu,Christopher D.M. Fletcher,AeRang Kim,Alexander J. Lazar,Martha Quezado,Karlyne M. Reilly,Anat Stemmer-Rachamimov,Douglas R. Stewart,David Viskochil,Brigitte C. Widemann,Arie Perry +11 more
TL;DR: The term "atypical neurofibromatous neoplasms of uncertain biologic potential (ANNUBP)" is proposed for lesions displaying at least 2 of the histopathologic features involved in the malignant transformation of neurof fibromas, and should prompt additional sampling, clinical correlation, and possibly, expert pathology consultation.
Journal ArticleDOI
DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies
Kris Ann P. Schultz,Gretchen M. Williams,Junne Kamihara,Douglas R. Stewart,Anne K. Harris,Andrew J. Bauer,Joyce Turner,Rachana Shah,Katherine A. Schneider,Kami Wolfe Schneider,Ann G. Carr,Laura A. Harney,Shari Baldinger,A. Lindsay Frazier,Daniel Orbach,Dominik T. Schneider,David Malkin,Louis P. Dehner,Yoav H. Messinger,D. Ashley Hill +19 more
TL;DR: Recommendations are provided for genetic testing; prenatal management; and surveillance for DICER1-associated pulmonary, renal, gynecologic, thyroid, ophthalmologic, otolaryngologic, and central nervous system tumors and gastrointestinal polyps.
Journal ArticleDOI
Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry.
Yoav H. Messinger,Douglas R. Stewart,John R. Priest,Gretchen M. Williams,Anne K. Harris,Kris Ann P. Schultz,Jiandong Yang,Leslie Doros,Philip S. Rosenberg,D. Ashley Hill,Louis P. Dehner +10 more
TL;DR: Pleuropulmonary blastoma (PPB) has 3 subtypes on a tumor progression pathway ranging from type I (cystic) to type II (Cystic/solid) and type III (completely solid).
Journal ArticleDOI
Family-based analysis of candidate genes for polycystic ovary syndrome.
Kathryn G. Ewens,Douglas R. Stewart,Wendy Ankener,Margrit Urbanek,Jan M. McAllister,Chen Chen,K. Maravet Baig,Stephen C. J. Parker,Elliot H. Margulies,Richard S. Legro,Andrea Dunaif,Jerome F. Strauss,Richard S. Spielman +12 more
TL;DR: A polymorphic variant, D19S884, in FBN3 is associated with risk of PCOS and POMC is also a candidate gene of interest.